Panbela Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
9.50
|
|
Average Rating
|
3.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
0
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.22
|
-0.21
|
0.01
|
4.55%
|
|
2022-06-30
|
-0.25
|
-1.51
|
-1.26
|
-504.00%
|
|
2022-03-31
|
-0.25
|
-0.27
|
-0.02
|
-8.00%
|
|
2021-12-31
|
-0.18
|
-0.26
|
-0.08
|
-44.44%
|
|
2021-09-30
|
-0.23
|
-0.16
|
0.07
|
30.43%
|
|
2021-06-30
|
-0.18
|
-0.22
|
-0.04
|
-22.22%
|
|
2021-03-31
|
-0.11
|
-0.23
|
-0.12
|
-109.09%
|
|
2020-12-31
|
-0.16
|
-0.09
|
0.07
|
43.75%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.99
|
|
2021-12-31
|
-0.87
|
|
2020-12-31
|
-0.63
|
|
2019-12-31
|
-1.14
|
|
2018-12-31
|
-1.32
|
|
2017-12-31
|
-4.59
|
|
2016-12-31
|
-1.63
|
|
2015-12-31
|
-2.01
|
|
2014-12-31
|
1.08
|